62 filings
8-K
SILO
SILO Pharma Inc
5 Apr 24
Other Events
4:01pm
8-K
SILO
SILO Pharma Inc
1 Feb 24
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
1:15pm
8-K/A
SILO
SILO Pharma Inc
11 Jan 24
Other Events
12:15pm
8-K
SILO
SILO Pharma Inc
9 Jan 24
Other Events
4:30pm
8-K
SILO
SILO Pharma Inc
11 Dec 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
gencwk yuh1svtxgwied
5 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
n9pe9sjv
4 Dec 23
Submission of Matters to a Vote of Security Holders
4:55pm
8-K
9a0zx b1j16
14 Nov 23
Entry into a Material Definitive Agreement
4:15pm
8-K
7d71mu f3u1j3dgbk4m
31 Aug 23
Other Events
7:30am
8-K
w591v 5mst2xph
29 Jun 23
Other Events
4:31pm
8-K
xjklfv h8d
27 Mar 23
Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia
9:05am
8-K
o44 2d158r
15 Feb 23
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
4:15pm
8-K
0ihr8
3 Feb 23
Silo Pharma Announces Expansion of Intellectual Property Portfolio
8:00am
8-K
56keoeue
31 Jan 23
Silo Pharma Announces Stock Repurchase Program
4:15pm
8-K
jqr3aru
20 Jan 23
Other Events
8:00am
8-K
d8b atsiwzfn
1 Dec 22
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
4:16pm
8-K
vqd9 ymxrvep2qwwnb
18 Oct 22
Entry into a Material Definitive Agreement
5:15pm
8-K
t9c l16nsn2fen0e7686
30 Sep 22
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
8:45am
8-K
kb7l56cz 0t20p
15 Sep 22
Silo Pharma Announces Implementation of 1-for-50 Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
5:24pm
8-K
y3u0wg1tni mzlew
11 Mar 22
Submission of Matters to a Vote of Security Holders
4:03pm